Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma
Ivo Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, et al.
The Lancet. Oncology
|
January 22, 2013
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
Dan Stark, Matthew Nankivell, Eric Pujade-Lauraine, et al.
Gynecologic Oncology
|
November 20, 2018
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
Antonio González Martín, Amit M Oza, Andrew C Embleton, et al.
Annals of Surgical Oncology
|
September 30, 2006
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
Philipp Harter, Andreas du Bois, Maik Hahmann, et al.
Acta Neuropathologica
|
January 5, 2018
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
Mathilde Small, Isabelle Treilleux, Coline Couillault, et al.
Gynecologic Oncology
|
July 21, 2019
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study
Linn Woelber, Christine Eulenburg, Jens Kosse, et al.
Gynecologic Oncology
|
June 23, 2019
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study
Rüdiger Klapdor, Linn Wölber, Lars Hanker, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
March 1, 2019
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions
Boris Winterhoff, Stefan Kommoss, Florian Heitz, et al.
The Oncologist
|
September 19, 2025
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer
B J Rimel, Eric Pujade-Lauraine, Kathleen Moore, et al.
Archives of Gynecology and Obstetrics
|
April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group
Ulrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma
Ivo Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, et al.
The Lancet. Oncology
|
January 22, 2013
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
Dan Stark, Matthew Nankivell, Eric Pujade-Lauraine, et al.
Gynecologic Oncology
|
November 20, 2018
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
Antonio González Martín, Amit M Oza, Andrew C Embleton, et al.
Annals of Surgical Oncology
|
September 30, 2006
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
Philipp Harter, Andreas du Bois, Maik Hahmann, et al.
Acta Neuropathologica
|
January 5, 2018
Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
Mathilde Small, Isabelle Treilleux, Coline Couillault, et al.
Gynecologic Oncology
|
July 21, 2019
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study
Linn Woelber, Christine Eulenburg, Jens Kosse, et al.
Gynecologic Oncology
|
June 23, 2019
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study
Rüdiger Klapdor, Linn Wölber, Lars Hanker, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
March 1, 2019
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions
Boris Winterhoff, Stefan Kommoss, Florian Heitz, et al.
The Oncologist
|
September 19, 2025
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer
B J Rimel, Eric Pujade-Lauraine, Kathleen Moore, et al.
Archives of Gynecology and Obstetrics
|
April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group
Ulrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.
Page
of 10